Archon Partners’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Archon Partners’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,625	Closed	-$234K	–	57
2015 Q4	$234K	Buy	+1,625	New	+$211K	0.06%	56

Other funds holding SIOX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Archon Partners's SIOX Position: Q1 2016 in Review

Archon Partners sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2016, closing a stake of 1,625 shares — an estimated $234K sold.

Archon Partners first reported a position in SIOX in Q4 2015 and held it in 1 quarter. The position peaked at $234K in Q4 2015. 70 funds tracked by Wall St. Rank hold SIOX as of Q1 2016.

Archon Partners reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
Archon Partners sold 1,625 Sio Gene Therapies Inc. Common Stock shares in Q1 2016, an estimated $234K.
Archon Partners first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 1 quarter.
Archon Partners's Sio Gene Therapies Inc. Common Stock position peaked at $234K in Q4 2015.
70 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2016.

Based on Archon Partners's 13F filing for Q1 2016, filed 16 May 2016.